Cvs Health (CVS) Long-Term Investments (2016 - 2026)

Cvs Health's Long-Term Investments history runs 11 years deep, the most recent figure standing at $32.4 billion for Q1 2026.

• Quarterly Long-Term Investments rose 12.11% year-over-year to $32.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.4 billion (up 12.11% YoY) and the FY2025 annual result came in at $34.8 billion, up 11.08% from the prior year.
• Long-Term Investments was $32.4 billion for Q1 2026 at Cvs Health, down from $34.8 billion in the prior quarter.
• Across five years, Long-Term Investments topped out at $34.8 billion in Q4 2025 and bottomed at $21.1 billion in Q4 2022.
• A 5-year average of $26.6 billion and a median of $25.2 billion in 2023 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2023 — Long-Term Investments declined 15.47% — and 2024, when it jumped 36.15%.
• Cvs Health's Long-Term Investments stood at $21.1 billion in 2022, then grew by 9.12% to $23.0 billion in 2023, then soared by 36.15% to $31.3 billion in 2024, then rose by 11.08% to $34.8 billion in 2025, then declined by 6.91% to $32.4 billion in 2026.
• Business Quant data shows CVS's Long-Term Investments at $32.4 billion in Q1 2026, $34.8 billion in Q4 2025, and $31.6 billion in Q3 2025.